Back to Evidence
Primary experimental recordPositive observation

PMC11945493::ACT014160

LFCA

Evidence text

Paper-level observation

Data analysis revealed that the 50% inhibitory concentration (IC50) of LFCA against FMDV was 203.9 μg/mL.
textConfidence: medium

Assay observation

Activity
Antiviral
Subtype
General Antiviral
Measure
other
Comparator
=
Raw observation
203.9 μg/mL
Normalized measurement
=203.9 µg/mL
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
PK-15
Assay method
Not reported by source
Sequence
FKCRRWQWRMKKLGAPSITCVRRAFGGGSSVDGKEDLIWKLLSKAQEKFGKNKSR
Standardization
ready simple

Source publication

Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in Mice.

Veterinary Sciences · 2025

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.